“…For example, microglia in an environment of amyloid induced neurodegeneration form a disease-associated microglia (DAM) (64), characterized by the downregulation of canonical microglial genes (P2ry12/13, Cx3cr1, Tmem119, Cst3) and upregulation of genes mapped to lipid metabolism pathways and phagocytosis (Apoe, Lpl, Cst7, Ctsd, Tyrobp, and Trem2). Certain genes, such as Hexb are stably expressed in homoeostatic microglia, DAM, and other neurological conditions (64,110). Elements of this DAM signature were later observed in microglia activated by diverse conditions such as following white matter injury (8,53), EAE (35), MS (78,82), amyloid lateral sclerosis (ALS) (64,111), ageing (53,111), facial nerve injury (112) and cancer (81).…”